Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy
about
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosisNon-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosisNonabsorbable disaccharides for hepatic encephalopathyAssimilation of lactitol, an 'unabsorbed' disaccharide in the normal human colonAmmonia toxicity to the brain.Nitrate reduction to nitrite, nitric oxide and ammonia by gut bacteria under physiological conditionsThe effect of lactulose supplementation on fecal microflora of patients with chronic kidney disease; a randomized clinical trial.Fibre and enteral nutrition.Effects of lactulose on nitrogen metabolism.Drinking hydrogen water and intermittent hydrogen gas exposure, but not lactulose or continuous hydrogen gas exposure, prevent 6-hydorxydopamine-induced Parkinson's disease in rats.Effect of protein and lactulose on the production of gamma-aminobutyric acid by faecal Escherichia coli.Status epilepticus after ligation of portosystemic shunts.Short-chain fatty acid formation in the hindgut of rats fed oligosaccharides varying in monomeric composition, degree of polymerisation and solubility.Lactitol and the maintenance of normal defecation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006The Pharmabiotic Approach to Treat Hyperammonemia.Effects of lactulose and lactitol on colonic microflora and enzymatic activity.
P2860
Q24185782-20C1C353-84A0-4F5D-A917-03A0ADCBAADCQ24185895-A7EA308C-75D8-4F35-8FFC-22B9BEB39AF8Q24247141-B5333746-86D9-4374-8FED-7964796E4625Q24548162-59CF8BF7-83D8-45CD-BBDB-38C3F55E5345Q30575263-EC36A5D3-3E68-450A-A431-BA1172FFBBD4Q35213744-E78BFF48-389D-4652-8A81-5B7E777825D0Q37291959-A6A2608C-2FF5-4714-A3B2-9CBE5A4CC6E7Q38267839-7447CF70-5F67-4B70-8A24-A40C9AFE5537Q41466142-19A452E8-9781-48B3-9E2A-34BD2F3F5CEAQ41761034-3D9D1F76-F743-42AE-BBA0-251BEFA152BCQ43220595-3BB07226-EAE1-4419-9BED-77F000957E49Q44582431-7DC26F52-5774-4985-90BD-0DA97B148273Q46796703-06A011D9-1C09-4194-AA09-9147989964E1Q47157341-C7729352-C58E-40EC-AFFD-D956467B2987Q47831420-66661FB2-6E02-4F68-B0E1-881431715FF1Q53447876-C985FEDF-C5C8-4DD4-A5AF-914CDCDE99C0
P2860
Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy
description
1987 nî lūn-bûn
@nan
1987 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի մարտին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Comparative modes of action of ...... ment of hepatic encephalopathy
@ast
Comparative modes of action of ...... ment of hepatic encephalopathy
@en
Comparative modes of action of ...... ment of hepatic encephalopathy
@nl
type
label
Comparative modes of action of ...... ment of hepatic encephalopathy
@ast
Comparative modes of action of ...... ment of hepatic encephalopathy
@en
Comparative modes of action of ...... ment of hepatic encephalopathy
@nl
prefLabel
Comparative modes of action of ...... ment of hepatic encephalopathy
@ast
Comparative modes of action of ...... ment of hepatic encephalopathy
@en
Comparative modes of action of ...... ment of hepatic encephalopathy
@nl
P2093
P2860
P3181
P356
P1433
P1476
Comparative modes of action of ...... ment of hepatic encephalopathy
@en
P2093
P2860
P304
P3181
P356
10.1136/GUT.28.3.255
P407
P577
1987-03-01T00:00:00Z